Results

eNauka >  Results >  A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy
Title: A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy
Authors: Gralla, R.J.; Bošnjak, Snežana  ; Hontsa, A.; Balser, C.; Rizzi, G.; Rossi, G.; Borroni, M.E.; Jordan, K.
Issue Date: 2014
Publication: Annals of Oncology.
ISSN: 0923-7534 Annals of Oncology Search Idenfier
Publisher: European Society Medical Oncology. ESMO. Oxford University Press.
Type: Article
Collation: vol. 25 br. 7 str. 1333-1339
DOI: 10.1093/annonc/mdu096
WoS-ID: 000339116500011
Scopus-ID: 2-s2.0-84903735622
PMID: 24631949
24631949
PMCID: PMC4071753
URI: https://enauka.gov.rs/handle/123456789/268600
URL: https://www.annalsofoncology.org/article/S0923-7534(19)36687-6/fulltext
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071753/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071753/pdf/mdu096.pdf
Metadata source: Migrirano iz RIS podataka
M-category: 
21aM21a

172
SCOPUSTM
84
PubMed CentralTM
129
OpenCitations
146
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.